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Actinomyces spp. are considered rare pathogens in today’s medicine, especially with thoracic vertebral
involvement. Classic actinomycosis (50%) presents as an oral-cervicofacial (“lumpy jaw”) infection. This
report describes a case of spinal cord compression caused by Actinomyces israelii with the coisolation of
Fusobacterium nucleatum. There are limited numbers of similar cases.
CASE REPORT
The case described here involves a 43-year-old Filipino man
who presented to a medical center emergency department with
a chief complaint of acute lower back pain and urinary incon-
tinence. He had been in his usual state of health until approx-
imately 3 days prior to admission, when he first noticed a
gradual onset of bilateral lower-extremity weakness, followed
by difficulty with walking and, finally, the inability to arise from
bed. In addition, the patient stated that he had been experi-
encing low-grade fevers and progressive weight loss over the
past several months. His medical history was unremarkable
and did not include any recent trauma. The patient had emi-
grated from the Philippines to Hawaii about 20 years earlier.
However, he denied any history of exposure to tuberculosis or
any recent travel back to the Philippines or Southeast Asia.
In the emergency room, the patient appeared to be disori-
ented, although he was able to follow simple commands. His
vital signs included a temperature of 97.8°F, blood pressure of
121/75 mm Hg, a heart rate of 116 beats/min, and mild tachy-
pnea, with an O2 saturation of 99% on room air. On physical
examination, he was noted to have poor dentition and evidence
of multiple previous dental extractions. A neurological exam-
ination revealed significant bilateral lower-extremity weakness
(two of five) with brisk deep-tendon reflexes, positive ankle
clonus, and a positive Babinski sign, as well as diminished
rectal tone. The remainder of the physical examination was
unremarkable. Laboratory blood findings were significant for
leukocytosis (22.0  109/liter) with 87% segmented neutro-
phils, an elevated platelet count of 722  106/liter, and an
erythrocyte sedimentation rate of 84 mm/h. A screen for hu-
man immunodeficiency virus type 1 and 2 antibodies was neg-
ative. The remaining laboratory findings were noncontributory.
A chest X ray showed a left-lower-lobe infiltrate with minimal
pleural effusion.
Because of the possibility of spinal cord compression and
injury, the patient was admitted to the medical intensive care
unit for further workup and management. This included mag-
netic resonance imaging of the spine, which showed an abnor-
mal signal intensity involving the thoracic vertebrae from T5
through T8 and an abnormal soft tissue mass enhancement
consistent with an apparent abscess that involved the left pos-
terior chest wall and ribs and that extended to the thoracic
vertebral column and into the epidural space, with apparent
spinal cord compression. A computed tomography scan of the
chest revealed similar abnormal findings involving the left pos-
terior chest wall and ribs as well as a collapsed left lower lobe
with minimal pleural effusion. A bone scan also showed in-
creased activity within the thoracic vertebrae and left ribs but
with no mention of bony erosion. The patient was started
empirically on intravenous (i.v.) antibiotics, consisting of ceftri-
axone at 2 g every 24 h and vancomycin at 1 g every 12 h, as
well as dexamethasone. This was followed immediately by an
emergent thoracic laminectomy and debridement of the epi-
dural abscess. Very thick fibrinous material was present over-
lying the dura, and several pockets of gross purulence were
seen from T5 to the superior aspect of T9. There was a well-
organized abscess running over the entire extent of exposure
and tapering at the rostral and caudal ends. Abscess fluid
samples for aerobic and anaerobic culture were obtained in-
traoperatively, placed in a BBL Port-A-Cul envelope (221607;
BD), and transported to the Microbiology Laboratory. The
wound was then irrigated with a copious volume of antibiotic-
containing saline and closed. The culture was positive for both
Actinomyces spp. and Fusobacterium spp. Blood and urine cul-
tures showed no growth. Stains for acid-fast bacilli and myco-
bacterial cultures were also negative.
The patient’s antibiotic regimen was changed to i.v. penicillin G
at 2  106 units every 4 h and clindamycin at 600 mg every 6 h.
Postoperatively, the surgical wound healed well without the ex-
pression of purulence. The patient’s bilateral lower-extremity mo-
tor strength improved markedly during his remaining hospital
course. However, residual bowel and urinary dysfunction still per-
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sisted. He was subsequently transferred to a rehabilitation center
for 6 weeks of i.v. antibiotic therapy consisting of penicillin G and
clindamycin. This was followed by 12 months of oral amoxicillin at
500 mg three times a day.
MATERIALS AND METHODS
Culture isolation and microscopy. A Gram stain was used to identify the
microscopic morphology of the isolates. Culture was performed with brucella
agar as the primary anaerobic medium. The Rapid ANA II system (API) was
used for the biochemical identification of the anaerobe.
PCR and sequencing. The identity of the isolate was confirmed by 16S rRNA
gene sequencing. A fragment of the 16S rRNA gene was amplified from DNA
extracted from the bacterial isolate by PCR with Pfu DNA polymerase, a PCR
mixture, and universal eukaryotic primers 27F and 1492R. The thermal cycling
conditions consisted of denaturation at 94°C for 3 min, followed by 30 cycles at
94°C for 45 s, 55°C for 45 s, and 72°C for 90 s. A final extension was carried out
at 72°C for 7 min, followed by cooling to 4°C. The PCR product was then purified
with a Qiagen PCR purification kit and sequenced with the following primers:
27F (AGAGTTTGATCMTGGCTCAG), 530R (GTA TTA CCG CGG CTG
CTG), 981R (GGG TTG CGC TCG TTG CGG G), and 1492R (TACGGYT
ACCTTGTTACGACTT). DNA sequencing was performed with a BigDye Ter-
minator cycle sequencing kit (version 3.1), and the sequence was resolved on an
ABI 3730XL DNA analyzer (Applied BioSystems, Foster City, CA). The full 16S
rRNA gene sequences were then assembled by use of the Seqman program
(DNAStar). Sequence analysis was performed with the ChromasPro program (ver-
sion 1.33; Technelysium Pty. Ltd.) and a search with the BLAST program
(www.ncbi.nlm.nih.gov/BLAST/BLAST.cgi).
RESULTS
Anaerobic culture of the epidural abscess resulted in the
isolation of both Actinomyces israelii (Fig. 1A) and Fusobacte-
rium nucleatum (Fig. 1B). Fusobacterium spp. are non-spore
forming and nonmotile. The classic microscopic description for
Fusobacterium spp. is a gram negative, spindle-shaped bacillus,
as revealed by this isolate and shown in Fig. 1B (10). The
identification of Fusobacterium nucleatum was confirmed with
the Rapid ANA II system (API). Both bacteria are commonly
found as a part of the normal flora in the human oral cavity.
However, it should be noted that once disruption of the mu-
cosa occurs, they can contribute to the development of a sys-
temic anaerobic infection.
FIG. 1. (A) Actinomyces israelii “molar tooth” appearance on sheep blood agar and microscopic morphology showing branching gram-positive
bacilli; (B) Fusobacterium nucleatum (larger colony) and A. israelii (smaller colony) colony morphology on sheep blood agar and microscopic
morphology showing fusiform gram-negative bacillus for F. nucleatum.
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Actinomyces spp. are gram-positive branching bacilli, which
often present with a beaded appearance on Gram stain (10).
They are characteristically identified as nonmotile, non-spore-
forming, non-acid-fast, and facultative anaerobes. These fea-
tures were present in the isolate from the case described here.
Culture isolates can be presumptively identified from both
their microscopic and macroscopic appearances, as outlined in
the algorithm in Fig. 2. This algorithm was constructed by one
of us (M.J.B.) from characteristics described in authoritative
microbiology reference textbooks (10, 18). However, definitive
identification relies upon complex phenotypic testing (i.e., car-
bohydrate fermentation, enzyme profiles, or gas chromatogra-
phy) or 16S rRNA sequencing. This isolate was identified from
the primary anaerobic culture (brucella agar) by both pheno-
typic and genotypic approaches. The isolate only grew anaer-
obically and exhibited the typical “molar tooth” appearance, as
demonstrated on a sheep blood agar plate (Fig. 1A).
The isolate was identified as A. israelii with a base identity
homologous to the sequence of A. israelii strain A1 (GenBank
accession no. AF479270.1) at 889/891 nucleotides (99.8%).
DISCUSSION
Classic actinomycosis is well documented as an oral-cervi-
cofacial (i.e., termed appropriately as “lumpy jaw”) lesion,
which occurs in approximately 55% of actinomycosis cases (2).
Infection occurs at other sites and is manifest as thoracic
(15%), abdominal and pelvic (20%), musculoskeletal (rare),
and central nervous system (rare) disease. However, actinomy-
cosis with the involvement of thoracic vertebral bone has rarely
been described (15).
Disruption of the mucosal membrane is essential for the
formation of actinomycosis. Once Actinomyces invades the tis-
sue of a disrupted mucus membrane, it slowly expands and
develops into an abscess. Classic actinomycosis usually occurs
following trauma, dental procedures, or other such surgical
procedures at sites where these bacteria may reside as part of
the normal flora.
Several risk factors for the development of actinomycosis
exist. It occurs more commonly in males, but there is no clear
explanation for this. Other risk factors may include poor oral
FIG. 1—Continued.




arch 22, 2014 by W






hygiene and the use of intrauterine devices. In addition, im-
munocompromise and other conditions, such as diabetes, al-
coholism, infections with immunosuppressive agents (e.g., hu-
man immunodeficiency virus), and steroid use, are thought to
predispose individuals to the development of actinomycosis (1,
4, 8, 20, 22).
The diagnosis of actinomycosis requires a high degree of
clinical suspicion, since Actinomyces spp. are insidious organ-
isms and infections with these organisms may show only non-
specific clinical manifestations (e.g., low-grade fever or other
constitutional symptoms) (22, 24). Even in a patient with tho-
racic vertebral actinomycosis, the clinical appearance does not
differ remarkably from that resulting from other diseases caus-
ing spinal cord compression, such as malignancy or an epidural
abscess (6, 22, 24).
Actinomyces was originally discovered in 1877 as a genus
containing the causative agent of actinomycosis in cattle.
Thereafter, in 1891, A. israelii was first isolated from a lung
abscess by Wolff and Israel (1, 22). Since then, other Actino-
myces spp. and related bacteria have been isolated and are
believed to be involved in a wide variety of human infections.
Oral infections have classically been linked to A. israelii. How-
ever, a number of other species have also been involved in
human infections. These include Actinomyces meyeri, Actino-
myces graevenitzii, Actinomyces turicensis, Actinomyces gerenc-
seriae, Actinomyces odontlyticus, Actinomyces cardiffensis, Acti-
nomyces radingae, Actinomyces naeslundii, other Actinomyces
spp., and a closely related species, Varibaculum cambriensis
(18, 22).
Members of the genus Actinomyces are frequently isolated
with other bacteria, including Fusobacterium spp., Bacteroides
spp., Capnocytophaga spp., Eikenella spp., Staphylococcus spp.,
Streptococcus spp., and Enterococcus spp. (1, 22). Although the
relationship between the coisolation of these organisms and
their role in the pathogenesis of actinomycosis still remains
unclear, the concomitant presence of other organisms may play
an important role in reducing oxygen tension, making it more
conducive for the growth of anaerobes. The coexistence of
those organisms may be related to both a common source and
their facilitation of the growth and development of Actinomy-
ces (11).
The vertebral involvement of actinomycosis is usually sec-
ondary to an infection of contiguous tissue rather than hema-
togenous spread. (6). Likewise, it is unlikely to be the result of
vertebral osteomyelitis and epidural abscesses due to common
bacterial pathogens.
A search of the literature from 1950 to 2007 revealed a total
of only 14 other cases of thoracic vertebral actinomycosis. The
present case is the 15th. These cases are listed in Table 1 (3, 6,
7, 9, 12, 13, 17, 19, 23, 24, 25, 26, 27). In summary, they show
that 9/15 (60%) were caused by A. israelii, the average age of
the patients was 42.2 years, 12/14 (85.7%) cases occurred in
males, and at least 8/12 (66.7%) cases were associated with
thoracic involvement or other pulmonary symptoms. In addi-
tion, another organism(s) was coisolated in 7/15 (46.7%) cases.
Epidemiological data in these cases were consistent with those
of other nonthoracic cases, even where the details were not
well documented.
Actinomycosis is sometimes difficult to differentiate from
mycobacterial disease (caused by both Mycobacterium tubercu-
losis and non-M. tuberculosis) and diseases caused by Nocardia
asteroides due to the similarities in the clinical manifestations
FIG. 2. Algorithm for the identification of gram-positive, non-spore-forming, branching/pleomorphic bacilli.
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and bacterial morphologies (6, 21, 22, 24). Identification of the
organism is critical, since the choice of antimicrobial agent(s)
differs for the treatment of infections caused by each bacterial
pathogen and may affect both patient morbidity and patient
mortality. In addition, Actinomyces spp. are slowly growing and
anaerobic; thus, optimal specimen collection requires an an-
aerobic culture and extended growth (possibly 14 to 21 days).
A proposed scheme for the identification of Actinomyces spp. is
described in Fig. 2.
The treatment of actinomycosis includes antimicrobial ther-
apy with or without surgery. Penicillin is the antibiotic of
choice, although other antimicrobial agents, such as clindamy-
cin, tetracycline, and erythromycin, can be used in cases of
penicillin allergy (14, 16). The optimal duration of antimicro-
bial therapy should be tailored depending on the severity of
illness. However, a longer duration of treatment with antimi-
crobial agents is usually necessary, since the premature termi-
nation of antimicrobial therapy may cause a relapse of actino-
mycosis (5). Conventional therapy dictates treatment with an
i.v. antimicrobial agent for 6 to 8 weeks, followed by treatment
with an oral antimicrobial agent for 6 to 12 months. Among the
cases listed in Table 1, 7/15 (46.7%) received antibiotic treat-
ment for 6 months or more.
The patient presented in this case study was diagnosed with
thoracic vertebral actinomycosis due to A. israelii. It is not
known how much Fusobacterium nucleatum contributed to the
infection or the role of this anaerobe in the pathogenesis of
actinomycosis. However, as suggested by others, it may be
reasonable to consider F. nucleatum as a potential copathogen
when treatment is considered (15). The most likely disease
progression was probably from an extension of a primary lung
infection (itself caused by the aspiration of oral flora), followed
by destruction of the ribs, the development of empyema, and
subsequent paraspinal abscess formation. The main risk factors
in the patient’s history were a history of alcoholism and poor
dentition.




Actinomyces species Yr Other bacterium species cultured Risk factor or diagnosis Country Duration of antimicrobialtherapy
43/M A. israelii Current case Fusobacterium nucleatum Rib osteomyelitis United States 6 wk of i.v. penicillin G
with i.v. clindamycin,
12 mo amoxicillin
51/M A. israelii 2006 None Pneumonia Israel 8 wk of i.v. penicillin
G, 12 mo of
amoxicillin
50/F A. israelii 2006 Bacteroides melaninogenicus None India 12 wk of oral ofloxacin
with rifampin
38/M A. israelii 2006 Fusobacterium spp. Alcohol abuse, cerebral
involvement
Denmark 8 wk of i.v.
metronidazole with
i.v. penicillin G, 12
mo of amoxicillin
32/M A. israelii 2000 None Mediastinal
involvement
China 6 wk of i.v. penicillin
G, 6 mo of oral
penicillin V
34/F Actinomyces spp. 1998 Actinobacillus actinomycetem-
comitans
None France 12 wk of oral ofloxacin
with rifampin
33/M Actinomyces spp. 1998 None None Japan 3 wk of piperacillin, 5
wk of oral
erythromycin
46/M Actinomyces spp. 1990 None Pneumonia, alcohol
abuse
United States 6 wk of i.v. penicillin
G, 12 mo of oral
penicillin G
56/M A. israelii 1989 None 9 mo cough United Kingdom 5 wk of i.v.
clindamycin, 3 wk of
oral clindamycin
40/M A. meyeri 1989 None Lung involvement Denmark 6 wk of penicillin G,
12 mo of oral
penicillin V
31/M A. israelii 1981 Propionibacterium acnes,
Enterococcus spp.
Cough United States Penicillin G (duration
not stated), 6 wk of
oral penicillin V
45/M A. israelii 1979 Actinobacillus actinomycetem-
comitans
Dental work United States Penicillin G and oral
ampicillin (duration
not stated)
52/M A. israelii 1979 Actinobacillus actinomycetem-
comitans
Lung involvement United States 8 wk of i.v. penicillin
G, 12 mo oral
penicillin V
42/M Actinomyces bovis 1960 None Cough, rib
osteomyelitis
United Kingdom 3 wk of i.v. penicillin G
42/NSb Actinomyces spp. 1951 None Lung involvement United Kingdom NSb
a M, male; F, female.
b NS, not indicated.
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Conclusion. Actinomyces spp. are often found as part of the
normal flora of the oral cavity and the gastrointestinal and
vaginal tracks. Actinomycosis can develop at virtually any site.
Due to the slow development of infection, attention to risk
factors during certain procedures (e.g., dental examination)
and a careful physical examination are especially important in
order to detect and treat the patient in the early stage of
actinomycosis. Since the hallmark of infection is the formation
of an abscess, surgical treatment may also be necessary, re-
gardless of the site of infection, in order to prevent the spread
of the disease.
Emphasis should be placed on having a high degree of clin-
ical suspicion and the use of appropriate techniques to obtain
a specimen adequate to achieve a successful diagnosis of acti-
nomycosis. The patient’s symptoms in this case improved with
surgical decompression and antimicrobial therapy. However,
the patient did not fully recover from urinary and bowel im-
pairment, despite appropriate treatment. Since actinomycosis
with thoracic vertebral column involvement is rarely encoun-
tered and reported, actinomycosis should be considered in
patients with spinal cord compression with risk factors, regard-
less of their clinical manifestation(s).
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